KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Goodwill & Intangibles: 2018-2024

Historic Goodwill & Intangibles for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $122.4 million.

  • Adaptive Biotechnologies' Goodwill & Intangibles fell 1.38% to $121.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.1 million, marking a year-over-year decrease of 1.38%. This contributed to the annual value of $122.4 million for FY2024, which is 12.13% down from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Goodwill & Intangibles of $122.4 million as of FY2024, which was down 12.13% from $139.3 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Goodwill & Intangibles registered a high of $139.3 million during FY2020, and its lowest value of $122.4 million during FY2024.
  • Its 3-year average for Goodwill & Intangibles is $133.7 million, with a median of $139.3 million in 2023.
  • Data for Adaptive Biotechnologies' Goodwill & Intangibles shows a maximum YoY fell of 12.13% (in 2024) over the last 5 years.
  • Adaptive Biotechnologies' Goodwill & Intangibles (Yearly) stood at $139.3 million in 2020, then remained steady at $139.3 million in 2021, then remained steady at $139.3 million in 2022, then remained steady at $139.3 million in 2023, then declined by 12.13% to $122.4 million in 2024.